{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T07:06:16Z","timestamp":1762067176915},"reference-count":20,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[1984,3,1]],"date-time":"1984-03-01T00:00:00Z","timestamp":446947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[1984,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Four compounds, 2[5(4\u2010chlorophenyl)pentyl] oxirane\u20102\u2010carboxylate (POCA), pent\u20104\u2010enoate, hypoglycin and valproate, which are hypoglycaemic in fasted animals and form unusual acyl\u2010CoA esters<jats:italic>in vivo<\/jats:italic>, inhibit mitochondrial \u03b2\u2010oxidation by different mechanisms. POCA, hypoglycin and valproate are known to cause dicarboxylic aciduria. Saturated dicarboxylic acids are thought to be derived from long chain fatty acids by peroxisomal \u03b2\u2010oxidation when mitochondrial \u03b2\u2010oxidation is severely impaired. The use of these inhibitors provides animal models of dicarboxylic aciduria found in some inborn errors of metabolism.<\/jats:p>","DOI":"10.1007\/bf03047375","type":"journal-article","created":{"date-parts":[[2009,6,25]],"date-time":"2009-06-25T03:36:15Z","timestamp":1245900975000},"page":"52-56","source":"Crossref","is-referenced-by-count":10,"title":["Animal models for dicarboxylic aciduria"],"prefix":"10.1002","volume":"7","author":[{"given":"H. S. A.","family":"Sherratt","sequence":"first","affiliation":[{"name":"Department of Pharmacological Sciences, Medical School University of Newcastle upon Tyne  Newcastle upon Tyne NE1 7RU UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. K.","family":"Veitch","sequence":"additional","affiliation":[{"name":"Department of Pharmacological Sciences, Medical School University of Newcastle upon Tyne  Newcastle upon Tyne NE1 7RU UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1984,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(78)90204-6"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01799807"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)50710-9"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.25.1.16"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1978.tb12707.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(78)80920-X"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.6.2043"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2944(80)90006-X"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(82)90258-2"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj2080749"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(73)90201-4"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2760(73)90132-X"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(76)90060-7"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02535365"},{"key":"e_1_2_1_16_1","first-page":"199","volume-title":"Short\u2010term Regulation of Liver Metabolism","author":"Sherratt H. S.","year":"1981"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90139-8"},{"key":"e_1_2_1_18_1","unstructured":"Sherratt H. S. A. Bartlett K.andTurnbull D. M.Four compounds that inhibit \u03b2\u2010oxidation: 2[5(4\u2010chlorophenyl)\u2010pentyl]ozirane\u20102\u2010carboxylate (POCA) hypoglycin pent\u20104\u2010enoate and valproate. A comparison of their mechanisms of action. InKabara J.%(ed%.%)The Pharmacological Role of Lipids a Monograph of the American Oil Association 1984(In press)."},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)44549-3"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197608262950901"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90054-0"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF03047375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/BF03047375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:32:06Z","timestamp":1694824326000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/BF03047375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,3]]},"references-count":20,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1984,3]]}},"alternative-id":["10.1007\/BF03047375"],"URL":"https:\/\/doi.org\/10.1007\/bf03047375","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,3]]}}}